verapamil has been researched along with n-benzyladriamycin-14-valerate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dockter, ME; Israel, M; Lothstein, L; Sweatman, TW | 1 |
| Koseki, Y; Lothstein, L; Sweatman, TW | 1 |
| Baumgart, J; Harstrick, A; Scheulen, ME; Schleucher, N; Schroeder, J; Seeber, S; Vanhoefer, U; Wilke, H | 1 |
3 other study(ies) available for verapamil and n-benzyladriamycin-14-valerate
| Article | Year |
|---|---|
Resistance to N-benzyladriamycin-14-valerate in mouse J774.2 cells: P-glycoprotein expression without reduced N-benzyladriamycin-14-valerate accumulation.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Cells, Cultured; Doxorubicin; Drug Resistance; Flow Cytometry; Macrophages; Membrane Glycoproteins; Mice; Microscopy, Fluorescence; RNA, Messenger; Verapamil; Vinblastine | 1992 |
P-glycoprotein overexpression in mouse cells does not correlate with resistance to N-benzyladriamycin-14-valerate (AD 198).
Topics: Affinity Labels; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Cells, Cultured; Dihydropyridines; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Immunoblotting; Mice; Tumor Cells, Cultured; Verapamil | 1994 |
Activity of N-benzyl-adriamycin-14-valerate (AD198), a new anthracycline derivate, in multidrug resistant human ovarian and breast carcinoma cell lines.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carcinoma; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Female; Flow Cytometry; Humans; Ovarian Neoplasms; Tumor Cells, Cultured; Verapamil | 1995 |